Inicio・Lista de Acciones・Zoetis Inc

Zoetis Inc

Cerrado

SectorSanidad

77.11 -0.3

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

76.87

Máximo

77.51

Métricas clave
By Trading Economics
Ingresos	-2M 601M
Ventas	-125M 2.3B
P/B Media del Sector	12.61 64.641
BPA	1.53
Rentabilidad por dividendo	2.69
Margen de beneficios	26.569
Empleados	14,500
EBITDA	-8M 939M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+28.58% upside

Dividendos
By Acuity
Rentabilidad por dividendo Media del Sector	2.69% 2.31%
Próximas Ganancias	6 ago 2026
Fecha Próximo Dividendo	1 sept 2026
Próxima Fecha de Ex Dividendo	30 oct 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-16B 32B
Apertura anterior	77.41
Cierre anterior	77.11

Noticias sobre sentimiento de mercado

By Acuity

59%

41%

275 / 340 Clasificación en Healthcare

Zoetis Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

1 ago 2026, 00:01 UTC

Zoetis Inc shares rose in after-market trading, recovering from an initial dip and reaching a high near the upper end of its one-month range.

31 jul 2026, 23:06 UTC

Zoetis Inc shares are higher in after-market trading, maintaining gains since Friday's close and remaining above the 20-day moving average.

30 jul 2026, 19:03 UTC

Zoetis Inc shares are lower, impacted by a decline in the Pharmaceuticals sub-sector. Earlier in the session, the stock peaked before falling.

29 jul 2026, 22:51 UTC

Zoetis Inc shares are trading lower in after-market hours. No specific news was identified to explain the decline amid broader market volatility.

28 jul 2026, 23:02 UTC

Zoetis Inc shares are higher in after-market trading, reflecting broader market strength amid investor optimism ahead of key earnings reports and the Federal Reserve meeting.

27 jul 2026, 23:16 UTC

News

Zoetis shares are lower in after-market hours following a class action lawsuit alleging securities fraud and reduced profit guidance to between $6.85 and $7.00 per share.

25 jul 2026, 00:01 UTC

Zoetis Inc. shares are trading higher in after-market hours, continuing a positive trend after closing higher for three consecutive sessions.

24 jul 2026, 21:02 UTC

Zoetis Inc shares are higher in after-market trading, rebounding from an initial dip despite a broader market decline influenced by disappointing earnings from Tesla and Alphabet.

23 jul 2026, 20:02 UTC

Zoetis Inc. shares are higher as strength in the pharmaceuticals sub-sector drives upward momentum, contributing to modest gains since Wednesday's close.

22 jul 2026, 21:02 UTC

Zoetis Inc. shares are lower in after-market trading, continuing a trend of five consecutive daily declines amid mixed market performance and rising crude oil prices.

21 jul 2026, 17:51 UTC

News

Zoetis Inc. shares are lower amid scrutiny from a securities fraud class action lawsuit alleging undisclosed market share declines and safety issues with Librela.

20 jul 2026, 23:16 UTC

Zoetis shares traded higher in after-market hours, maintaining stability above Monday's close despite broader market pressures from rising treasury yields.

Comparación entre iguales

Cambio de precio

Zoetis Inc previsión

Precio Objetivo

By TipRanks

28.58% repunte

Estimación a 12 Meses

Media 99.38 USD 28.58%

Máximo 130 USD

Mínimo 85 USD

De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Zoetis Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

12 ratings

Comprar

Mantener

Vender

De acuerdo con 12 analistas que ofrecen calificaciones bursátiles a para Zoetis Inc Dist en los últimos 3 meses.

Sentimiento

By Acuity

275 / 340 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.